胃肠肿瘤术后早期腹腔并全身化疗30例

30 Patients of Gastroenteril Carcinoma Intraperitoneal Chemotherapy

摘要: 目的研究术后早期腹腔内化疗与胃肠肿瘤术后生存率的关系。方法用术后早期腹腔内化疗并MF全身化疗的方法治疗了30 例经病理确诊的胃肠癌中， Ⅲ～Ⅳ期占83 %.结果在30 例病人中， 1、2 、5 年生存率分别为86-6 %, 63-3 %, 6-6 %, 其中2 例胃癌病人生存了6年。结论术后早期腹腔内化疗并MF方案全身化疗对胃肠癌术后腹腔复发和肝转移有预防作用。

Abstract: Objective To evaluate clinical features, effective treatment and prognosis of colorectal and gastric carcinoma Methods Histologic slides of 30 cases from 1989 to 1996 of colorectal and gastric carcinoma with the early postoperative intraperitoneal chemotherapy and MF(MMC 5FU) chemotherapy were treated. Results Two patients with gastric carcinoma survived for 6-year. In 30 evaluable patients, the overall 1、2 and 5year survival rates were 86.6%,63.3% and 6.6%. Conclusion The early postoperative intraperitoneal chemotherapy and MF(MMC-5FU) chemotherapy are of advantage in preventing and treating tum or recurrence in the peritoneal cavity and hepatic metastases